Consensus best practice pathway of the UK Systemic Sclerosis Study group

management of cardiac disease in systemic sclerosis

Lesley-Anne Bissell, Marina Anderson, Malcolm Burgess, Kuntal Chakravarty, Gerry Coghlan, Raluca B Dumitru, Lee Graham, Voon Ong, John D Pauling, Sven Plein, Dominik Schlosshan, Peter Woolfson, Maya H Buch

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Objective. Cardiac disease in SSc can manifest in various ways and is associated with a poor prognosis. There is little evidence on how best to detect and manage cardiac disease in SSc. Our objective was to produce an expert consensus best practice pathway for the management of cardiac disease in SSc.

Methods. The UK Systemic Sclerosis Study Group set up several working groups to develop a number of consensus best practice pathways for the management of SSc-specific complications, including cardiac disease. A multidisciplinary task force was convened. The guidelines were partly informed by a comprehensive literature review.

Results. A best practice pathway for cardiac disease (with a focus on primary cardiac disease) in SSc is presented, including approaches for early detection and standard pharmacological and device therapies. Due to the benefits, shared care and a multidisciplinary approach are recommended. A future research agenda has been formulated in response to the relative lack of understanding of the natural history of primary cardiac disease that was highlighted by the initiative.

Conclusion. The physician should be alert to the possibility of cardiac disease in SSc; it is best managed within a multidisciplinary team including both rheumatologists and cardiologists. This pathway provides a reference for all physicians managing patients with SSc.
Original languageEnglish
Pages (from-to)912-921
JournalRheumatology
Volume56
Issue number6
Early online date4 Feb 2017
DOIs
Publication statusPublished - 1 Jun 2017

Fingerprint

Systemic Scleroderma
Practice Guidelines
Heart Diseases
Practice Management
Physicians
Advisory Committees
Pharmacology
Guidelines
Equipment and Supplies

Keywords

  • Journal Article

Cite this

Bissell, L-A., Anderson, M., Burgess, M., Chakravarty, K., Coghlan, G., Dumitru, R. B., ... Buch, M. H. (2017). Consensus best practice pathway of the UK Systemic Sclerosis Study group: management of cardiac disease in systemic sclerosis. Rheumatology, 56(6), 912-921. https://doi.org/10.1093/rheumatology/kew488

Consensus best practice pathway of the UK Systemic Sclerosis Study group : management of cardiac disease in systemic sclerosis. / Bissell, Lesley-Anne; Anderson, Marina; Burgess, Malcolm; Chakravarty, Kuntal; Coghlan, Gerry; Dumitru, Raluca B; Graham, Lee; Ong, Voon; Pauling, John D; Plein, Sven; Schlosshan, Dominik; Woolfson, Peter; Buch, Maya H.

In: Rheumatology, Vol. 56, No. 6, 01.06.2017, p. 912-921.

Research output: Contribution to journalArticle

Bissell, L-A, Anderson, M, Burgess, M, Chakravarty, K, Coghlan, G, Dumitru, RB, Graham, L, Ong, V, Pauling, JD, Plein, S, Schlosshan, D, Woolfson, P & Buch, MH 2017, 'Consensus best practice pathway of the UK Systemic Sclerosis Study group: management of cardiac disease in systemic sclerosis', Rheumatology, vol. 56, no. 6, pp. 912-921. https://doi.org/10.1093/rheumatology/kew488
Bissell, Lesley-Anne ; Anderson, Marina ; Burgess, Malcolm ; Chakravarty, Kuntal ; Coghlan, Gerry ; Dumitru, Raluca B ; Graham, Lee ; Ong, Voon ; Pauling, John D ; Plein, Sven ; Schlosshan, Dominik ; Woolfson, Peter ; Buch, Maya H. / Consensus best practice pathway of the UK Systemic Sclerosis Study group : management of cardiac disease in systemic sclerosis. In: Rheumatology. 2017 ; Vol. 56, No. 6. pp. 912-921.
@article{ba15ebe534694c889cdb33aff05b114a,
title = "Consensus best practice pathway of the UK Systemic Sclerosis Study group: management of cardiac disease in systemic sclerosis",
abstract = "Objective. Cardiac disease in SSc can manifest in various ways and is associated with a poor prognosis. There is little evidence on how best to detect and manage cardiac disease in SSc. Our objective was to produce an expert consensus best practice pathway for the management of cardiac disease in SSc.Methods. The UK Systemic Sclerosis Study Group set up several working groups to develop a number of consensus best practice pathways for the management of SSc-specific complications, including cardiac disease. A multidisciplinary task force was convened. The guidelines were partly informed by a comprehensive literature review.Results. A best practice pathway for cardiac disease (with a focus on primary cardiac disease) in SSc is presented, including approaches for early detection and standard pharmacological and device therapies. Due to the benefits, shared care and a multidisciplinary approach are recommended. A future research agenda has been formulated in response to the relative lack of understanding of the natural history of primary cardiac disease that was highlighted by the initiative.Conclusion. The physician should be alert to the possibility of cardiac disease in SSc; it is best managed within a multidisciplinary team including both rheumatologists and cardiologists. This pathway provides a reference for all physicians managing patients with SSc.",
keywords = "Journal Article",
author = "Lesley-Anne Bissell and Marina Anderson and Malcolm Burgess and Kuntal Chakravarty and Gerry Coghlan and Dumitru, {Raluca B} and Lee Graham and Voon Ong and Pauling, {John D} and Sven Plein and Dominik Schlosshan and Peter Woolfson and Buch, {Maya H}",
year = "2017",
month = "6",
day = "1",
doi = "10.1093/rheumatology/kew488",
language = "English",
volume = "56",
pages = "912--921",
journal = "Rheumatology",
issn = "1462-0324",
publisher = "Oxford University Press",
number = "6",

}

TY - JOUR

T1 - Consensus best practice pathway of the UK Systemic Sclerosis Study group

T2 - management of cardiac disease in systemic sclerosis

AU - Bissell, Lesley-Anne

AU - Anderson, Marina

AU - Burgess, Malcolm

AU - Chakravarty, Kuntal

AU - Coghlan, Gerry

AU - Dumitru, Raluca B

AU - Graham, Lee

AU - Ong, Voon

AU - Pauling, John D

AU - Plein, Sven

AU - Schlosshan, Dominik

AU - Woolfson, Peter

AU - Buch, Maya H

PY - 2017/6/1

Y1 - 2017/6/1

N2 - Objective. Cardiac disease in SSc can manifest in various ways and is associated with a poor prognosis. There is little evidence on how best to detect and manage cardiac disease in SSc. Our objective was to produce an expert consensus best practice pathway for the management of cardiac disease in SSc.Methods. The UK Systemic Sclerosis Study Group set up several working groups to develop a number of consensus best practice pathways for the management of SSc-specific complications, including cardiac disease. A multidisciplinary task force was convened. The guidelines were partly informed by a comprehensive literature review.Results. A best practice pathway for cardiac disease (with a focus on primary cardiac disease) in SSc is presented, including approaches for early detection and standard pharmacological and device therapies. Due to the benefits, shared care and a multidisciplinary approach are recommended. A future research agenda has been formulated in response to the relative lack of understanding of the natural history of primary cardiac disease that was highlighted by the initiative.Conclusion. The physician should be alert to the possibility of cardiac disease in SSc; it is best managed within a multidisciplinary team including both rheumatologists and cardiologists. This pathway provides a reference for all physicians managing patients with SSc.

AB - Objective. Cardiac disease in SSc can manifest in various ways and is associated with a poor prognosis. There is little evidence on how best to detect and manage cardiac disease in SSc. Our objective was to produce an expert consensus best practice pathway for the management of cardiac disease in SSc.Methods. The UK Systemic Sclerosis Study Group set up several working groups to develop a number of consensus best practice pathways for the management of SSc-specific complications, including cardiac disease. A multidisciplinary task force was convened. The guidelines were partly informed by a comprehensive literature review.Results. A best practice pathway for cardiac disease (with a focus on primary cardiac disease) in SSc is presented, including approaches for early detection and standard pharmacological and device therapies. Due to the benefits, shared care and a multidisciplinary approach are recommended. A future research agenda has been formulated in response to the relative lack of understanding of the natural history of primary cardiac disease that was highlighted by the initiative.Conclusion. The physician should be alert to the possibility of cardiac disease in SSc; it is best managed within a multidisciplinary team including both rheumatologists and cardiologists. This pathway provides a reference for all physicians managing patients with SSc.

KW - Journal Article

UR - http://dx.doi.org/10.1093/rheumatology/kew488

U2 - 10.1093/rheumatology/kew488

DO - 10.1093/rheumatology/kew488

M3 - Article

VL - 56

SP - 912

EP - 921

JO - Rheumatology

JF - Rheumatology

SN - 1462-0324

IS - 6

ER -